[go: up one dir, main page]

UA109238C2 - Method for the selection of acute hepatitis c treatment policy - Google Patents

Method for the selection of acute hepatitis c treatment policy

Info

Publication number
UA109238C2
UA109238C2 UAA201407998A UAA201407998A UA109238C2 UA 109238 C2 UA109238 C2 UA 109238C2 UA A201407998 A UAA201407998 A UA A201407998A UA A201407998 A UAA201407998 A UA A201407998A UA 109238 C2 UA109238 C2 UA 109238C2
Authority
UA
Ukraine
Prior art keywords
selection
treatment policy
acute hepatitis
week
present
Prior art date
Application number
UAA201407998A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Сергій Валерійович Федорченко
Жанна Борисівна Клименко
Ольга Василівна Ляшок
Тетяна Леонідівна Мартинович
Original Assignee
Державна Установа "Інститут Епідеміології Та Інфекційних Хвороб Ім. Л.В. Громашевського Національної Академії Медичних Наук України"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державна Установа "Інститут Епідеміології Та Інфекційних Хвороб Ім. Л.В. Громашевського Національної Академії Медичних Наук України" filed Critical Державна Установа "Інститут Епідеміології Та Інфекційних Хвороб Ім. Л.В. Громашевського Національної Академії Медичних Наук України"
Priority to UAA201407998A priority Critical patent/UA109238C2/en
Publication of UA109238C2 publication Critical patent/UA109238C2/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a method for the selection of acute hepatitis C treatment policy involves the prediction of hepatitis course by analysis of combination of cytokine gene polymorphisms, wherein determined are RNA-HCV in blood serum, IL-28B gene polymorphism by alleles rs 12979860 and rs 8099917, and if genetic associations CC/TT are present the antiviral therapy begins from 20th week from disease debut, and if genetic associations CT/TG or TT/TG are present the therapy begins after 12th week from disease debut.
UAA201407998A 2014-07-15 2014-07-15 Method for the selection of acute hepatitis c treatment policy UA109238C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201407998A UA109238C2 (en) 2014-07-15 2014-07-15 Method for the selection of acute hepatitis c treatment policy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201407998A UA109238C2 (en) 2014-07-15 2014-07-15 Method for the selection of acute hepatitis c treatment policy

Publications (1)

Publication Number Publication Date
UA109238C2 true UA109238C2 (en) 2015-07-27

Family

ID=53721224

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201407998A UA109238C2 (en) 2014-07-15 2014-07-15 Method for the selection of acute hepatitis c treatment policy

Country Status (1)

Country Link
UA (1) UA109238C2 (en)

Similar Documents

Publication Publication Date Title
MX2022016381A (en) Oligonucleotides for inducing paternal ube3a expression.
LT3505174T (en) DEOXYNUCLEOSIDE THERAPY FOR THE TREATMENT OF DISEASES CAUSED BY UNBALANCED LEVELS OF NUCLEOTIDES, INCLUDING MITOCHONDRESS DNA TRACKING SYNDROMES
EP3626832A3 (en) Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
WO2008089465A3 (en) Gene polymorphisms as sex-specific predictors in cancer therapy
TW201612518A (en) Methods of identifying patients suffering from liver cancer who will most likely benefit from a treatment with an antagonist anti-FGFR4 antibody
MX2016005003A (en) Genetic markers predictive of response to glatiramer acetate.
WO2008088855A3 (en) Gene polymorphisms as predictors of tumor progression and their use in cancer therapy
WO2008088876A3 (en) Tissue factor promoter polymorphisms
UA109238C2 (en) Method for the selection of acute hepatitis c treatment policy
RU2014110824A (en) METHOD FOR FORECASTING THE RISK OF MITTING THE FIRST HALF OF PREGNANCY
EP3378481A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING OR TREATING LIVER, IMPROVING THE PATHOLOGIES CAUSED BY LIVER, SWEETENED DIABETES OR OTHER ASSOCIATED DISEASES
UA95236U (en) Method of choosing technique for acute viral hepatitis c treatment
WO2017095918A3 (en) Methods for treating cancer using rspo3 antagonists
WO2017211843A8 (en) Antiviral polyclonal antibodies against ebola virus and the uses thereof
RU2015134878A (en) METHOD FOR PREDICTING THE RISK OF SUBARAHNOIDAL HEMORRHEMIA AS A RESULT OF Rupturing of the Brain Vascular Aneurysm in Persons of the Asian Race
UA96043U (en) A method for predicting fracture healing
叶芳 Higher apolipoprotein B levels are associated with earlier onset of first-ever atherosclerotic stroke
UA106739U (en) A method for predicting fracture healing
Crude WDFY4 rs7097397 A/G polymorphisms and risk of rheumatoid arthritis in 429 cases and 797 controls.
TH163160A (en)
UA106762U (en) A method for predicting fracture healing
UA106731U (en) A method for predicting fracture healing
UA106753U (en) A method for predicting fracture healing
Bakken New'living document'provides real-time Hepatitis C treatment guidance
RU2014130617A (en) A method for the early diagnosis of atherosclerosis